Outcomes of BsAbs after CAR-T failure depending on the time point of CAR-T failure (early vs intermediate/late) and BsAb administration (first vs later salvage). (A) PFS in Pts with early relapse after CAR-Ts; (B) OS rates in Pts with early relapse after CAR-Ts; (C) PFS in Pts with intermediate/late relapse after CAR-Ts; and (D) OS rates in Pts with intermediate/late relapse after CAR-Ts; Pts at risk are highlighted below the Kaplan-Meier plot.